PTGX: Protagonist Therapeutics Inc Bozor kapitallashuvi
Protagonist Therapeutics (PTGX) xalqaro logistikani optimallashtirish uchun dori ishlab chiqarish va sinovlarini tashqi pudratchilarga topshiradi. Baholash vositasi bo'lib xizmat qiluvchi GURU.Markets saytidagi ushbu grafik 8.79 miqdoridagi bozor kapitalizatsiyasini ko'rsatmoqda. Biznesning o'sishi xarajatlarni kamaytiruvchi royalti to'lovlari orqali peptid patentlarini tijoratlashtirishga tayanadi. Noyob tadqiqot bazasi muvaffaqiyat uchun asos yaratib, Protagonist Therapeutics (PTGX) kompaniyasini eksklyuziv ittifoqlar orqali sanoat yetakchilari bilan bog'laydi.
Protagonist Corp (PTGX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- emitentning balans qiymati statistikasi:
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Umumiy qarzning kapitalga nisbati Protagonist Therapeutics|PTGX - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Protagonist Therapeutics|PTGX - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Protagonist Corp|PTGX - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzi Protagonist Therapeutics|Tezkor likvidlik koeffitsiyenti protagonist-inc.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
PTGX - Sof foyda|Kelajakdagi foyda Protagonist Therapeutics|PTGX - Kompaniya qiymatining sof foydaga nisbati|Forvard P/E multiplikatori Protagonist Therapeutics Inc|PTGX - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Protagonist Corp|PTGX - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Protagonist Therapeutics|PTGX - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi protagonist-inc.com|PTGX - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Protagonist Therapeutics
Kompaniyaning fundamental tahlili:PTGX (Protagonist)
Protagonist Therapeutics (PTGX) barqarorligi peptid dori vositalarini ishlab chiqish bo'yicha strategik sherikliklarga tayanadi, bu esa uning bozor kapitalizatsiyasini kelajakdagi pul oqimlariga bo'lgan bozor kutuvlarining aniq ko'rsatkichi qiladi. Joriy aksiya narxi va chiqarilgan qimmatli qog'ozlar umumiy sonining ko'paytmasini ifodalovchi ushbu metrika, tasodifiy bozor tebranishlarini filtrlagan holda, kompaniyaning umumiy kapital qiymati orqali biznesning haqiqiy qiymatini real vaqt rejimida baholash imkonini beradi.
Muhim raqobatchilar
argenx - Bozor bahosi|Bozor qiymati BNTX (BioNTech Inc.)|Abivax S.A. - Bozor kapitallashuvi|Bozor kapitallashuvi ADMA Corp (ADMA)|IMVT (Immunovant, Inc.) - Bozor bahosi|Bozor kapitallashuvi KNSA|Bozor qiymati Grifols|Adaptive Biotech - Bozor bahosi|Bozor kapitallashuvi CLDX|AUPH (Aurinia Corp) - Bozor qiymati|Bozor kapitallashuvi BCRX (BioCryst)|Bozor kapitallashuvi veratx.com VERA|DNTH - Bozor qiymati|Bozor qiymati PHVS (Pharvaris NV)|AbCellera (ABCL) - Bozor qiymati|Bozor bahosi Tourmaline|PGEN (Precigen, Inc.) - Bozor kapitallashuvi|Bozor kapitallashuvi pharming.com|Bozor bahosi NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio, Inc.) - Bozor qiymati|Bozor kapitallashuvi ZBIO (Zenas Biopharma, Inc.)|Bozor kapitallashuvi Immunome Bio (IMNM)|GOSS - Bozor qiymati|kalvista.com (KALV) - Bozor bahosi|Septerna (SEPN) - Bozor qiymati|Bozor bahosi Pieris Pharma|Bozor bahosi SVRA|Bozor kapitallashuvi Rigel Corp|Bozor qiymati AnaptysBio, Inc. (ANAB)|astriatx.com - Bozor kapitallashuvi|Bozor kapitallashuvi ENGN (enGene)|rapt.com (RAPT) - Bozor qiymati|JBIO - Bozor qiymati|Bozor bahosi ACRS|Kyverna Therapeutics (KYTX) - Bozor qiymati|tizianalifesciences.com - Bozor qiymati|Bozor qiymati Cabaletta Bio|Bozor qiymati Ventyx Biosciences Inc. VTYX|Bozor bahosi THTX (Theratechnologies Inc)|Bozor qiymati AVTX|Bozor kapitallashuvi ELDN (Eledon Pharmaceuticals)|Bozor kapitallashuvi agenusbio.com AGEN|Climb Bio - Bozor kapitallashuvi|Bozor kapitallashuvi zurabio.com (ZURA)|aTyr (ATYR) - Bozor qiymati|Bozor qiymati Adagene Inc. (ADAG)|Bozor qiymati ImageneBio|Bozor kapitallashuvi STTK (Shattuck Therapeutics)|Bozor kapitallashuvi EQ|Bozor kapitallashuvi connectbiopharm.com|Bozor qiymati Immunic IMUX|Bozor kapitallashuvi Atara Biotherapeutics, Inc. (ATRA)|IFRX: Bozor bahosi|x4pharma.com - Bozor qiymati|ACET (adicetbio.com) - Bozor bahosi|Celularity - Bozor qiymati|Bozor bahosi INMB|BRNS (Barinthus Biotherapeutics Corp) - Bozor qiymati|Bozor kapitallashuvi KZR|SABS (sabbiotherapeutics.com) - Bozor qiymati|Bozor kapitallashuvi AKTX (Akari Therapeutics Plc)|Enlivex Therapeutics Ltd (ENLV) - Bozor qiymati|QTTB - Bozor qiymati|Bozor qiymati GOVX (GeoVax Corp)|EDSA: Bozor kapitallashuvi|ibioinc.com (IBIO) - Bozor kapitallashuvi|Bozor qiymati Carisma Therapeutics Inc|XTL Biopharmaceuticals Ltd - Bozor bahosi|Bozor kapitallashuvi BOLT|HCWB - Bozor qiymati|Aptevo Therapeutics Inc. - Bozor bahosi|Bozor kapitallashuvi aimimmuno.com AIM|ADTX: Bozor bahosi|GRI Bio Inc - Bozor qiymati|XRTX: Bozor kapitallashuvi|HIND - Bozor kapitallashuvi|REVB (Revelation Biosciences) - Bozor kapitallashuvi|Bozor bahosi indaptusrx.com (INDP)|Bozor qiymati Scinai Immunotherapeutics Ltd. (SCNI)|Bozor kapitallashuvi calcimedica.com|Bozor qiymati Affimed N.V. AFMD|ALLK (Allakos Inc) - Bozor bahosi|HOOK: Bozor bahosi|IGM Biosciences, Inc. - Bozor qiymati|ITOS: Bozor kapitallashuvi|Bozor kapitallashuvi Ocean Biomedical Inc OCEA|Bozor bahosi TCBP|Bozor kapitallashuvi THRD (Third Harmonic Bio Inc)
